Atika Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-114,500
Closed -$37.3M 120
2024
Q1
$37.3M Buy
114,500
+13,000
+13% +$3.19M 3.67% 3
2023
Q4
$19.3M Sell
101,500
-15,000
-13% -$2.83M 2.59% 7
2023
Q3
$23.2M Sell
116,500
-2,000
-2% -$473K 3.04% 4
2023
Q2
$33.8M Buy
118,500
+500
+0.4% +$139K 3.39% 4
2023
Q1
$25.6M Sell
118,000
-4,593
-4% -$895K 3.78% 4
2022
Q4
$25.2M Sell
122,593
-10,182
-8% -$2.57M 3.62% 6
2022
Q3
$36.9M Sell
132,775
-142,225
-52% -$36.2M 3.13% 5
2022
Q2
$52.6M Sell
275,000
-12,500
-4% -$2.21M 5.91% 1
2022
Q1
$59.6M Buy
287,500
+163,200
+131% +$26.9M 5.02% 2
2021
Q4
$22.2M Buy
124,300
+2,000
+2% +$394K 1.56% 25
2021
Q3
$25.2M Buy
122,300
+800
+0.7% +$157K 1.5% 17
2021
Q2
$23.1M Hold
121,500
1.82% 16
2021
Q1
$15.8M Sell
121,500
-13,500
-10% -$1.62M 1.37% 22
2020
Q4
$14M Buy
135,000
+17,000
+14% +$1.47M 1.1% 36
2020
Q3
$8.95M Buy
+118,000
New +$6.69M 0.73% 48
2020
Q1
Sell
-24,100
Closed -$1.06M 108
2019
Q4
$1.06M Buy
+24,100
New +$890K 0.2% 71

Other funds holding SWAV

Atika Capital Management's SWAV Position: Q2 2024 in Review

Atika Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 114,500 shares — an estimated $37.3M sold.

Atika Capital Management first reported a position in SWAV in Q4 2019 and held it in 16 quarters. The position peaked at $59.6M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Atika Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Atika Capital Management sold 114,500 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $37.3M.
  • Atika Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Atika Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $59.6M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.